Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 307 of 5804
-
New inhaled therapy aims to slow lung scarring in IPF
Disease control Recruiting nowThis study will evaluate the impact Nintedanib Solution for Inhalation (AP02) has on lung function and key measures of fibrosis in adult patients with idiopathic pulmonary fibrosis (IPF) as well as assess its safety and tolerability. Adults 40 years of age or older with IPF who …
Phase: PHASE2 • Sponsor: Avalyn Pharma Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New pill aims to calm lupus skin flares in major trial
Disease control Recruiting nowThe purpose of this global, multicenter, Phase 3 study is to evaluate the efficacy and safety of enpatoran over 24 weeks in participants with active cutaneous manifestations of lupus erythematosus with or without systemic disease. Study details include: Study Duration: Up to 35 …
Phase: PHASE3 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
No X-Rays, no dye: new heart valve procedure could protect kidneys
Disease control Not yet recruitingTranscatheter aortic valve replacement (TAVR) is an established therapy for severe aortic valve disease, yet conventional workflows rely on fluoroscopy and iodinated contrast, exposing patients and operators to ionizing radiation and posing challenges for individuals with chronic…
Phase: NA • Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
AI eye doctor: new model diagnoses diseases from photos
Diagnosis Recruiting nowAccurate and comprehensive interpretation of anterior segment diseases from slit-lamp and smartphone photographs remains a clinical challenge due to the limited specificity and structure of existing Artificial Intelligence tools. The purpose of this international, multicenter cli…
Sponsor: Guangdong Provincial People's Hospital • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Smart MRI tailors cancer therapy for better outcomes
Disease control Not yet recruitingFUTURE-3 was a prospective, multicenter, single-arm phase II study designed to explore the efficacy and safety of MRI-guided individualized chemoradiotherapy for locally advanced esophageal squamous cell carcinoma. The primary endpoint was one-year progression-free survival rate.
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Swab test could spot hidden uterine cancer early
Diagnosis Recruiting nowThis is a multicenter, prospective, specimen collection study for development and evaluation of tests used to detect endometrial cancer, other cancers, or their causes.
Sponsor: Exact Sciences Corporation • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Can a drug cocktail save Insulin-Making cells in newly diagnosed kids?
Disease control Recruiting nowThis multi-center randomized controlled trial will assess the safety and efficacy of ATG followed by either adalimumab or verapamil in preserving insulin secretion 2 years from randomization in persons aged 9 to \<21 with recent-onset stage 3 T1D.
Phase: PHASE1, PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for lung cancer patients: experimental drug SYS6010 faces off against chemotherapy
Disease control Not yet recruitingThis is a randomized, open-label, multicenter Phase III clinical trial, designed to evaluate the efficacy and safety of SYS6010 versus docetaxel in participants with Locally Advanced or Metastatic EGFR Wild-type Non-squamous Non-small Cell Lung Cancer who Have Failed Standard The…
Phase: PHASE3 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Exercise after stroke may shield brain from dementia
Disease control Recruiting nowThe rates of cognitive decline and dementia after stroke are disproportionately high. Strategies that can protect the brain early after the stroke event could reduce the future risk of cognitive decline and dementia in these patients. Although physical exercise is usually recomme…
Phase: NA • Sponsor: McGill University • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Pedaling soon after paralysis: new trial aims to speed recovery
Disease control Recruiting nowSpinal cord injuries (SCI) are among the most catastrophic survivable events experienced by human beings. Affected individuals remain with lifelong neurological impairment involving motor, sensory, bladder and bowel functions, which in turn impacts quality of life and independenc…
Phase: NA • Sponsor: Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Could a single pill stop lyme disease before it starts?
Prevention OngoingThis study is designed to evaluate the safety, tolerability, and pharmacokinetics of TP05 administered orally to healthy adult participants.
Phase: PHASE2 • Sponsor: Tarsus Pharmaceuticals, Inc. • Aim: Prevention
Last updated Jul 11, 2026 00:00 UTC
-
New scan could spot 'Invisible' brain tumors in Cushing's patients
Diagnosis Recruiting nowThis study is designed as a single institution trial. The study utilizes safe and clinically-validated tools for preoperative workup of patients with small pituitary tumors. DDAVP stimulation and 18F-labeled fluoro-deoxyglucose (FDG) uptake for PET-imaging will be used to detect …
Phase: NA • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Diagnosis
Last updated Jun 27, 2026 12:05 UTC
-
New targeted drug hopes to shrink NRAS-Driven cancers
Disease control Recruiting nowThis is a Phase 1 first-in-human, open-label multicenter study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary antitumor activity of RLY-8161, an NRAS-selective inhibitor, in participants with advanced NRAS-mutant melanoma a…
Phase: PHASE1 • Sponsor: Relay Therapeutics, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Immunotherapy-Chemo cocktail aims to tame head and neck tumors
Disease control Recruiting nowThis research study is being done to assess the safety and tolerability of toripalimab in combination with cisplatin and docetaxel (PDT) induction therapy for patients with CPS-positive locally advanced head and neck squamous cell carcinoma (HNSCC).
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Hormone cycling: a new hope for advanced prostate cancer?
Disease control Recruiting nowThe objective of this study is to determine the safety and clinical effects of alternating pharmacologic (i.e. supraphysiologic) testosterone therapy with darolutamide in men with metastatic prostate cancer as first line hormonal therapy. Correlative studies will be conducted to …
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New injection could save heart muscle after attack
Disease control Recruiting nowThis is a multicenter, randomized, double-blind, placebo-controlled, single-dose, Phase II clinical study to evaluate the efficacy, safety, and pharmacokinetic (PK) characteristics of SGC001 injection administered in addition to standard clinical care in Chinese patients with acu…
Phase: PHASE2 • Sponsor: Beijing Sungen Biomedical Technology Co., Ltd • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New drug 608 aims to ease hidden arthritis pain
Disease control Not yet recruitingThis study will evaluate the efficacy and safety of 608 in patients with nr-axSpA.
Phase: PHASE3 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
AI heart scanner could catch silent disease in thousands
Diagnosis Recruiting nowA study to evaluate feasibility, diagnostic yield, accuracy, and actionable thresholds of POC, immediate-feedback AI-ECG + AI FoCUS screening for cardiac disease in well described community populations.
Phase: NA • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC
-
New hope for young brain cancer patients: enzyme therapy targets tumors
Disease control Not yet recruitingThis is an open label, intra-patient dose escalation, to evaluate ADI-PEG 20, in combination with Temozolomide (TMZ) and radiation therapy (RT) in children, adolescents and young adult patients with newly diagnosed high grade glioma (HGG).
Phase: PHASE1, PHASE2 • Sponsor: Sabine Mueller, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New drug combo aims to shrink kidney tumors before surgery
Disease control Recruiting nowThe purpose of this study is to see whether the drug casdatifan is safe and effective either by itself or in combination with the drug zimberelimab in participants with resectable clear cell renal cell carcinoma (ccRCC). The names of the study drugs involved in this study are: …
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC